MRI影像组学在肝细胞癌诊疗和预后评估中的研究进展  

Progress in MRI based radiomics in diagnosis and prognosis assessment of hepatocellular carcinoma

作　　者：张坤 谢双双[1] 沈文(审校)[1] ZHANG Kun;XIE Shuangshuang;SHEN Wen(Department of Radiology,Tianjin First Central Hospital,Tianjin Institute of Imaging Medicine,Tianjin 300192,China)

机构地区：[1]天津市第一中心医院放射科,天津市影像医学研究所,天津300192

出　　处：《国际医学放射学杂志》2022年第4期454-458,共5页International Journal of Medical Radiology

基　　金：国家自然科学基金面上资助项目(81873888);国家自然科学基金青年基金资助项目(81901710);天津市卫生健康委员会青年人才项目(TJWJ2021QN011);天津市卫生健康委员会青年项目(QN20024);天津市医学重点学科(专科)建设项目(TJYXZDXK-041A)。

摘　　要：肝细胞癌(HCC)具有显著的异质性,且发病率和术后复发率较高。MRI影像组学对其临床诊断和治疗预后评估具有重要作用。相较于传统影像学的宏观特征分析,MRI影像组学能够高通量地提取定量的微观图像特征,目前已逐步应用于HCC的鉴别诊断、病理分级、微血管侵犯预测以及手术预后和非手术疗效评估等方面。就MRI影像组学在HCC诊疗和预后评估中的研究进展予以综述。Hepatocellular carcinoma(HCC)has significant heterogeneity,and the incidence and postoperative recurrence rate are high.MRI-based radiomics plays an important role in clinical diagnosis and prognosis evaluation in HCC.Compared with the macroscopic feature analysis of traditional imaging,radiomics based on MRI can extract quantitative microscopic image features,which has been gradually applied in the differential diagnosis,pathological classification,microvascular invasion,and efficacy evaluation of surgical and non-surgical treatments.The progress of MRI-based radiomics in the diagnosis and prognosis evaluation of HCC were reviewed.

关 键 词：肝细胞癌 磁共振成像 鉴别诊断 预后评估 影像组学 

分 类 号：R735.7[医药卫生—肿瘤] R445.2[医药卫生—临床医学]